Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Multiple Myeloma 2Breast Neoplasms 2Uveal Melanoma 1Small Cell Lung Carcinoma 1Prolactin-Producing Pituitary Tumor 1Pituitary ACTH Hypersecretion 1Neoplasm Metastasis 1Metastatic Solid Tumor Cancers 1Lung Neoplasms 1Glioma 1Glioblastoma 1Depression 1Cushing Syndrome 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Cancer Caregivers 1Anxiety Disorders 1

Interventions

Temozolomide 264Radiotherapy 119Bevacizumab 105Magnetic Resonance Spectroscopy 59Radiation 47pembrolizumab 30Irinotecan 28Surgical Procedures, Operative 23Lomustine 21Specimen Handling 19Nivolumab 19Radiosurgery 18Carmustine 18Aminolevulinic Acid 16Erlotinib Hydrochloride 15Drug Therapy 15Blood Specimen Collection 14Radiotherapy, Intensity-Modulated 13O(6)-benzylguanine 13Chemotherapy, Adjuvant 13Carboplatin 13Filgrastim 11Cyclophosphamide 11sargramostim 10poly ICLC 10atezolizumab 10Thalidomide 10Etoposide 10Ipilimumab 9Everolimus 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Glioblastoma × 4-amino-4'-hydroxylaminodiphenylsulfone × Clear all
NCT03975959 2026-06-04

PROMESSE

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Completed
426 enrolled
BreastCNS

Breast Neoplasms, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡